Maryam AlQaseer Consultant Cardiologist King Fahad Specialist

Transcription

Maryam AlQaseer Consultant Cardiologist King Fahad Specialist
Maryam AlQaseer
Consultant Cardiologist
King Fahad Specialist Hospital in Dammam
Sub-investigator in SHIFT, REVERESE, ATMOSPHERE, REPORT-HF








2 brief case histories
Outline of management of HFrEF management..
What do the guidelines say..
Recent evidence and therapeutic options..
Pharmacotherapy
Devices
Surgical interventions
Glimpse into the future outlook of heart failure



53 year old gentleman with no previous medical illnesses gets
admitted via ER with a history of progressively worsening sob
for 4 weeks, orthopnoea and PND.
He denied any chest pain
Very good baseline effort tolerance, works as a grave digger.





Examination was positive for sinus tachycardia of 110bpm.
BP128/71mmHg, SpO2 93% on room air and RR24bpm.
Elevated JVP 8cm H2O
S1, S2, S3, no murmurs.
Bibasal crepitations
Minimal pitting pedal oedema at the level of ankles.
ECG: Sinus tachycardia with
LBBB
 Troponin was mildly elevated,
BNP 1050, Normal RFT, CBC,
Iron profile and TSH.
 ECHO
 CAG normal coronaries.




Started on anti-failure therapy and sent home after education
Regular f/u at the HFU managed to take him up to bisoprolol
10mg, spironolactone 25mg od, perindopril 10mg od, lasix
40mg od, and warfarin as per INR.
3 months after OMT brought him back for an echo, LV
function remains same and LV thrombus disappeared.




CRT-D implanted, and brought him back in 6 weeks after
implant.
Device check was good and BiV pacing about 97% of the time.
An echo was done, EF~50%.
Patient is back to working 70-80 hour weeks





29 year old gentleman, smoker, history of myocarditis which
improved 3 years ago lost to follow up and stopped
medications.
Comes back with a history of recent URTI and was in florid
pulmonary oedema.
SBP~80-90mmHg. Required NIPPV.
Bloods BNP of 3450, Troponin mildly elevated, Normal RFT,
CBC, Iron, TSH, Non specific ECG changes
CAG: Normal coronaries








Bisoprolol 10mg od, spironolactone25mg od, valsartan 80 mg BD,
lasix 40mg BD, and warfarin as per INR.
3 months after OMT still severe LV dysfunction.
Narrow QRS.
ICD rejected.
Recurrent admissions with heart failure 4x/year, needed inotropes
once.
Right heart cath, elevated PAP.
INTERMACS class 6-7
Awaiting heart transplant.
Studies working towards the upcoming ESC HF
guidelines in 2016
ESC HF Guidelines 2012
1987CONSENS
US
1991SOLVED
•
•
•
•
3 components:
ACE-i/ARB--------- -ARN-i
BB
MRA
1991- V
HEFTII
1996CARVEDI
LOL
HEART
FAILURE
GROUP
1997- DIG
TRIAL
1999RALES
2001-VALHEFT
2001COPERNI
CUS
2011EMPHASI
S HF
2014PARADIG
M-HF
It’s not only about the addition of
drugs but rather achieving the
target doses of therapy
Courtesy of ESC slides 2015
1. CHRONIC STABLE HF
2. CLASS II-III
3. WITHOUT SIGNIFICANT
HYPOTENSION
4. WITHOUT SIGNIFICANT RENAL
IMPAIRMENT
ARN-i
Courtesy of ESC slides 2015

Iron therapy
IRONMAN TRIAL.. Results awaited..
2004COMPANION
2005- CARE
HF
2005- SCD
HeFT
2009- MADIT
CRT
2010- RAFT
2013- ECHO
CRT
2014- MADIT
CRT
TAKE HOME MSG, Consider CRT if:
•
•
•
•
Severe LV systolic dysfunction, EF < 35% despite OMT
NYHA II or more
LBBB
Or alternatively, non LBBB preferably >150 msec
TWO CAVEATS..
•
•
If Class IV, expected to live for a year with a good
functional status.
If Afib, ensure adequate BiV pacing, or else will need
concomitant AVN ablation
TAKE HOME MESSAGE:
•
Severe LV systolic dysfunction, EF < 35% despite OMT
•
NYHA II or more
•
Narrow QRS
CAVEAT..
The patient needs to know that this will NOT improve their
symptoms but rather improve their sudden cardiac death(SCD)risk..
The patients at highest risk of SCD are those in Class II



INTERMACS
Evidence of Heart Tx
Evidence of MCS









Establishing a Heart Failure Unit
Education to the patient
Education to the staff
Checklists
CPGs
Clinical pathways
Minimize variation
Start early from admission
Prevention is Key.. Target those at risk before they get HF.. Stage
A HF..




ARN-i
ATMOSPHERE
Where do we draw line between HFpEF vs HFrEF
PRADA
Courtesy of ESC slides 2015

CABG

ICD vs CRT





OMT
Sinus rhythm
NYHA II or more
Resting HR > 70bpm
Target HR ~ 50-60 bpm